Clinical Research Directory
Browse clinical research sites, groups, and studies.
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute
Summary
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
Official title: Efficacy Of High-Dose Rosuvastatin Preloading Before Primary Percutaneous Coronary Intervention In Patients Suffering From St-Elevation Myocardial Infarction
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2024-12-02
Completion Date
2025-07-02
Last Updated
2025-04-11
Healthy Volunteers
No
Interventions
Statin monotherapy (rosuvastatin or atorvastatin)
Tab Rosuvastatin 40mg (weight) at presentation. Tab Rosuvastatin 20mg at night for 30 days.
Placebo
Placebo caspule
Locations (2)
Shaikh Zayed Hsopital
Lahore, Pakistan
Punjab Institute of Cardiology
Lahore, Pakistan